|Beads Size||2 mg||10 mg|
|Particle size||2 μm||2 μm|
|Amount of protein coupled||>300nmol /mg Beads||>300nmol /mg Beads|
|Binding Capacity||> 200 nmol antibody/ mg beads||> 200 nmol antibody / mg beads|
|Formulation||Lyophilized from 0.22 μm filtered solution in PBS, 0.05% Tween-20, pH7.4, with 10% trehalose||Lyophilized from 0.22 μm filtered solution in PBS, 0.05% Tween-20, pH7.4, with 10% trehalose|
|Reconstitution||2 mL ultrapure water (1mg beads/mL)||10 mL ultrapure water (1mg beads/mL)|
The target antibodies can be captured with the antigen pre-coupled beads from a mixture, and then be dissociated from the beads.
Biopanning is an affinity selection technique which selects for peptides that binds to a given target. In the capturing step, just add the antigen couple beads to your phage library. Simply use a magnet to separate the bound phages from the unbound ones. More efficient and time saving compared to the plate-based capture.
Flow cytometric analysis
This antigen coupled beads can be used as feeder cells (antigen-presenting cells) to run your flow cytometric analysis, but without the hassle of cell culture.
Upon receipt, please store the Beads at -20℃. The shelf life is 1 year at -20 ℃.
An immediate use is highly recommended after reconstitution.
Do not to freeze thaw the Beads after reconstitution.
High quality SARS-CoV-2 S protein, S1 protein and human ACE2 protein based on the human cell expression platform of HEK293.
ACROBiosystems has developed a series of homogeneous CD3 proteins with good bioactivity. They are verified as 1:1 heterodimers by nonreductive electrophoresis and MALS as well.
ACRO screened a few different beads and bring this tightly controlled superparamagnetic microspheres to you. This product can be widely applied for immunocapture, bio panning and flow cytometry.
ACROBiosystems has developed a series of kit products using its high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development.
This web search service is supported by Google Inc.